North Carolina A&T University-Wake Forest Cancer Center partnership (2 of 2)

北卡罗来纳州A

• 批准号: 8135336
• 负责人: YONG Q CHEN
• 金额: $ 11.83万
• 依托单位: WAKE FOREST UNIVERSITY HEALTH SCIENCES
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-09-25 至 2013-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8135336
• 关键词: 3-hydroxybutanal; Agriculture; Animal Cancer Model; Animal Model; Biological Assay; Biology; Boronic Acids; Brain Neoplasms; CCL7 gene; Cancer Biology; Cancer Center; Cell Line; Cell Mobility; Cell model; Cells; Chemistry; Chemoprevention; Chemopreventive Agent; Collaborations; Comprehensive Cancer Center; Comprehensive Cancer Center of Wake Forest University; Computational Biology; DU145; Data; Doctor of Philosophy; Educational process of instructing; Engineering; Enrollment; Enzymes; Evaluation; Faculty; Fostering; Funding; Funding Agency; GSTP1 gene; Genetic; Glioblastoma; Goals; Grant; Growth; Hour; In Vitro; Incidence; Institution; Joints; Knock-out; LNCaP; Laboratories; Malignant Epithelial Cell; Malignant Neoplasms; Malignant neoplasm of prostate; Master' s Degree; Measurement; Mentors; Methods; Minority; Modeling; Mus; NAD(P)H dehydrogenase (quinone) 1, human; NQO1 gene; North Carolina; PTEN gene; Phase; Physical condensation; Pilot Projects; Polyunsaturated Fatty Acids; Preparation; Process; Production; Prostate; Prostate carcinoma; Research; Research Project Grants; Resistance; Reverse Transcriptase Polymerase Chain Reaction; Role; Structure-Activity Relationship; Students; Testing; Therapeutic; Universities; Western Blotting; Writing; anticancer research; base; cancer cell; cancer genomics; cancer health disparity; cancer therapy; carcinogenesis; career development; cytotoxicity; enzyme activity; evidence base; forest; health disparity; in vivo; in vivo Model; innovation; interest; mouse model; novel; outreach; prevent; professor; programs; transcription factor; treatment strategy; university student

DESCRIPTION (provided by applicant): This P20 proposal presents a research and educational partnership between the Wake Forest University Comprehensive Cancer Center (WFUCCC) and the Departments of Biology and Chemistry of North Carolina Agricultural and Technical University (NC A&T). The objectives of the partnership are: (1) to foster cancer research collaborations between WFUCCC and NC A&T, especially research focused on cancer disparities and to facilitate the career development of minority cancer research faculty at NC A&T through collaborations with and mentoring provided by the WFUCCC; (2) to foster interest in obtaining a PhD in cancer biology among minority undergraduate and Master's degree students at NC A&T. To achieve the first objective, the P20 will provide pilot funds for two collaborative research projects: (1) Drs. Suzy Torti and Yong Chen of the WFUCCC will mentor and collaborate with Dr. Marion Franks, Assistant Professor of Chemistry at NC A&T, on a project to synthesize and evaluate novel benzylidenes as prostate cancer chemopreventive agents; (2) Dr. Waldemar Debinski, Director of the Brain Tumor Center of the WFUCCC, will mentor and collaborate with Dr. Patrick Martin, Assistant Professor of Biology at NC A&T on a project to understand the role of transcription factor Fra1 in glioblastoma cell mobility and resistance to therapeutics. To achieve the second objective: (1) Selected RISE, MARC, and BLEND program undergraduates at NC A&T will participate in wet laboratory, computational biology, or health disparity outreach projects mentored by WFUCCC faculty; (2) Each pilot project team will select at least one NC A&T Master's degree student to ; participate in the project. The students will be offered the option of continued participation in the projects as PhD students in Cancer Biology at WFU; (3) WFUCCC and NC A&T faculty will collaborate to develop didactic teaching modules in cancer genomics and animal models of cancer for currently ongoing coursework at NC A&T. By the conclusion of the P20 it is expected that: (1) Drs. Franks and Martin and their WFUCCC collaborators will be writing joint RO1s; (2) The WFUCCC and NC A&T will be writing an R25 bridge application to support enrollment of NC A&T students in the PhD program in Cancer Biology at WFU.

描述（由申请人提供）：本P20提案介绍了维克森林大学综合癌症中心（WFUCCC）与北卡罗来纳州农业技术大学（NC A&T）生物和化学系之间的研究和教育合作关系。该伙伴关系的目标是：（1）促进WFUCCC和NC A&T之间的癌症研究合作，特别是关注癌症差异的研究，并通过与WFUCCC的合作和指导促进NC A&T少数癌症研究人员的职业发展;（2）培养NC A&T少数民族本科生和硕士生获得癌症生物学博士学位的兴趣。为了实现第一个目标，P20将为两个合作研究项目提供试点资金：（1）WFUCCC的Suzy Torti博士和Yong Chen博士将指导并与NC A&T的化学助理教授Marion Franks博士合作，进行一项合成和评估新型苯亚甲基作为前列腺癌化学预防剂的项目;（2）WFUCCC脑肿瘤中心主任Waldemar Debinski博士将指导并与NC A&T生物学助理教授帕特里克马丁博士合作开展一个项目，以了解转录因子Fra 1在胶质母细胞瘤细胞移动性和对治疗药物的抵抗中的作用。为了实现第二个目标：（1）选择上升，MARC，并在NC A&T融合程序本科生将参加湿实验室，计算生物学，或健康差距外展项目由WFUCCC教师指导;（2）每个试点项目团队将选择至少一个NC A&T硕士学位的学生;参与该项目。学生将被提供继续参与项目的选择，作为WFU癌症生物学的博士生;（3）WFUCCC和NC A&T教师将合作开发癌症基因组学和癌症动物模型的教学模块，用于NC A&T目前正在进行的课程。到P20结束时，预计：（1）弗兰克斯博士和马丁博士及其WFUCCC合作者将编写联合RO 1;（2）WFUCCC和NC A&T将编写R25桥接应用程序，以支持NC A&T学生在WFU癌症生物学博士课程中的入学。